HuGE Literature Finder
Records
1
-
8
The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients. PloS one 2021 16 (4): e0250597. Furuse Maizumi, Hosomi Shuhei, Nishida Yu, Itani Shigehiro, Nadatani Yuji, Fukunaga Shusei, Otani Koji, Tanaka Fumio, Nagami Yasuaki, Taira Koichi, Kamata Noriko, Watanabe Toshio, Watanabe Kenji, Fujiwara Yasuhi |
CYP3A5 Genotype as a Potential Pharmacodynamic Biomarker for Tacrolimus Therapy in Ulcerative Colitis in Japanese Patients. International journal of molecular sciences 2020 6 21 (12): . Yamamoto Yuki, Nakase Hiroshi, Matsuura Minoru, Maruyama Shihoko, Masuda Satohi |
Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis. Intestinal research 2019 Feb . Okabayashi Shinji, Kobayashi Taku, Saito Eiko, Toyonaga Takahiko, Ozaki Ryo, Sagami Shintaro, Nakano Masaru, Tanaka Junichi, Yagisawa Keiji, Kuronuma Satoshi, Takeuchi Osamu, Hibi Toshifu |
Monitoring of peripheral blood cluster of differentiation 4 adenosine triphosphate activity and CYP3A5 genotype to determine the pharmacokinetics, clinical effects and complications of tacrolimus in patients with autoimmune diseases. Experimental and therapeutic medicine 2018 Jan 15 (1): 532-538. Muraki Yuichi, Mizuno Shugo, Nakatani Kaname, Wakabayashi Hiroki, Ishikawa Eiji, Araki Toshimitsu, Taniguchi Akira, Isaji Shuji, Okuda Masahi |
ATP-binding cassette subfamily B member 1 1236C/T polymorphism significantly affects the therapeutic outcome of tacrolimus in patients with refractory ulcerative colitis. Journal of gastroenterology and hepatology 2017 Jan . Onodera Motoyuki, Endo Katsuya, Kakuta Yoichi, Kuroha Masatake, Kimura Tomoya, Hiramoto Keiichiro, Kanazawa Yoshitake, Negoro Kenichi, Shiga Hisashi, Kinouchi Yoshitaka, Shimosegawa Too |
The effect of CYP3A5 genetic polymorphisms on adverse events in patients with ulcerative colitis treated with tacrolimus. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2017 Jan 49 (1): 24-28. Asada Ayumi, Bamba Shigeki, Morita Yukihiro, Takahashi Kenichiro, Imaeda Hirotsugu, Nishida Atsushi, Inatomi Osamu, Sugimoto Mitsushige, Sasaki Masaya, Andoh Aki |
Impact of CYP3A5 genetic polymorphisms on the pharmacokinetics and short-term remission in patients with ulcerative colitis treated with tacrolimus. Journal of gastroenterology and hepatology 2014 Jan 29 (1): 60-6. Hirai Fumihito, Takatsu Noritaka, Yano Yutaka, Satou Yuhou, Takahashi Haruhiko, Ishikawa Satoshi, Tsurumi Kozue, Hisabe Takashi, Matsui Toshiyu |
ABCB1 single-nucleotide polymorphisms determine tacrolimus response in patients with ulcerative colitis. Clinical pharmacology and therapeutics 2011 Mar 89 (3): 422-8. Herrlinger K R, Koc H, Winter S, Teml A, Stange E F, Fellermann K, Fritz P, Schwab M, Schaeffeler |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: